Universität zu Köln

Journal Article

Bishop, Michael R., Maziarz, Richard T., Waller, Edmund K. ORCID: 0000-0003-0816-6729, Jaeger, Ulrich, Westin, Jason R., McGuirk, Joseph P., Fleury, Isabelle, Holte, Harald ORCID: 0000-0001-9799-9428, Borchmann, Peter, del Corral, Christopher, Tiwari, Ranjan, Anak, Oezlem, Awasthi, Rakesh, Pacaud, Lida, Romanov, Vadim V. and Schuster, Stephen J. (2019). Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion. Blood Adv., 3 (14). S. 2230 - 2237. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 2473-9537

Fowler, Nathan Hale, Dickinson, Michael, Dreyling, Martin, Martinez-Lopez, Joaquin, Kolstad, Arne, Butler, Jason ORCID: 0000-0002-6422-4404, Ghosh, Monalisa, Popplewell, Leslie, Chavez, Julio C., Bachy, Emmanuel, Kato, Koji, Harigae, Hideo, Kersten, Marie Jose, Andreadis, Charalambos, Riedell, Peter A., Ho, P. Joy, Perez-Simon, Jose Antonio, Chen, Andy, I, Nastoupil, Loretta J., von Tresckow, Bastian, Ferreri, Andres Jose Maria, Teshima, Takanori, Patten, Piers E. M., McGuirk, Joseph P., Petzer, Andreas L., Offner, Fritz, Viardot, Andreas, Zinzani, Pier Luigi, Malladi, Ram, Zia, Aiesha, Awasthi, Rakesh, Masood, Aisha, Anak, Oezlem, Schuster, Stephen J. and Thieblemont, Catherine (2022). Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial. Nat. Med., 28 (2). S. 325 - 343. BERLIN: NATURE PORTFOLIO. ISSN 1546-170X

Maziarz, Richard T., Bishop, Michael R., Tam, Constantine S., Borchmann, Peter, Jaeger, Ulrich, McGuirk, Joseph, Waller, Edmund K., Jaglowski, Samantha, Andreadis, Charalambos, Foley, Stephen Ronan, Fleury, Isabelle, Mielke, Stephan, Westin, Jason R., Ho, Phoebe Joy, Bachanova, Veronika, Holte, Harald, Magenau, John M., Anak, Oezlem, Pacaud, Lida Bubuteishvili, Guenther, Siegbert, Zhang, Jie, Rasouliyan, Lawrence, Tai, Feng, Salles, Gilles A. and Schuster, Stephen J. (2018). Patient-Reported Quality of Life (QoL) Following Tisagenlecleucel Infusion in Adult Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL). Bone Marrow Transplant., 53. S. 177 - 179. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Schuster, Stephen, Bishop, Michael R., Tam, Constantine, Waller, Edmund K., Borchmann, Peter, McGuirk, Joseph, Jaeger, Ulrich, Jaglowski, Samantha, Andreadis, Charalambos, Westin, Jason, Fleury, Isabelle, Bachanova, Veronika, Foley, Stephen Ronan, Ho, P. Joy, Mielke, Stephan, Magenau, John M., Holte, Harald, Anak, Oezlem, Pacaud, Lida, Awasthi, Rakesh, Tai, Feng, Salles, Gilles and Maziarz, Richard T. (2017). Global Pivotal Phase 2 Trial of the CD19-Targeted Therapy CTL019 In Adult Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)-An Interim Analysis. Clin. Lymphoma Myeloma Leuk., 17. S. S373 - 2. DALLAS: CIG MEDIA GROUP, LP. ISSN 2152-2669